Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Not applicable Interventional

Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in End Stage Renal Disease (ESRD)

ClinicalTrials.gov ID: NCT01017627

Public ClinicalTrials.gov record NCT01017627. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 3:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Case Controlled Study to Determine the Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in ESRD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The investigators hypothesize that the post-hospitalized patient status is characterized by subacute and reversible metabolic and hematological changes that, if addressed and treated in a timely manner, would result in a reduced risk for repeat hospitalization. Consequently, a structured quality improvement program, focused on increasing adherence to company wide anemia management policies (ie hemoglobin monitoring within the first 3-5 days post-hospitalization, followed by an appropriate EPO dose modification within the 7 days post-hospitalization), will significantly decrease the risk of hospital re-admission in the 30 days after discharge.

Study identification

NCT ID
NCT01017627
Recruitment status
Not listed
Study type
Interventional
Phase
Not applicable
Enrollment
1,500 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2009 (Type not available)
Primary completion
Nov 2010 (Estimated)
Completion
Dec 2010 (Estimated)
Last update posted
Apr 2, 2010

2009 – 2010

United States locations

U.S. sites
42
U.S. states
16
U.S. cities
36
Facility City State ZIP Site status
Denver Central Denver Colorado 80209 —
St. John's Jacksonville Florida 32246 —
JAX Beach Jacksonville Florida 32250 —
Prairie Chicago Illinois 60616 —
Tri Counties Decatur Indiana 46733 —
Huntington Huntington Indiana 46750 —
Floyd County New Albany Indiana 47150 —
South Louisville Louisville Kentucky 40216 —
Breaux Bridge Breaux Bridge Louisiana 70517 —
Delta Delta Louisiana 71233 —
East Lafayette Lafayette Louisiana 70501 —
Methuen Methuen Massachusetts 01844 —
Roxbury Roxbury Massachusetts 02119 —
Battle Creek Battle Creek Michigan 49014 —
East Lansing East Lansing Michigan 48823 —
Oshtemo Kalamazoo Michigan 49009 —
Lansing Lansing Michigan 48911 —
Saganaw Riverside Saginaw Michigan 48602 —
Saginaw Saginaw Michigan 48602 —
Eupora Eupora Mississippi 39744 —
Meridian Meridian Mississippi 39301 —
Yokna River Oxford Mississippi 38655 —
Independence Centerpoint Independence Missouri 64057 —
Desert Inn Las Vegas Nevada 89109 —
South Pecos Las Vegas Nevada 89120 —
Briggs Ave Durham North Carolina 27703 —
Freedom Lake Durham North Carolina 27704 —
Boardman Boardman Ohio 44512 —
Cortland Cortland Ohio 44410 —
Elyria Elyria Ohio 44035 —
North Randall North Randall Ohio 44128 —
Westlake Westlake Ohio 44145 —
Willoughby Willoughby Ohio 44094 —
Twin Oaks Beaverton Oregon 97006 —
Clackamas Clackamas Oregon 97015 —
Fresenius Medical Services Brentwood Tennessee 37027 —
Smyrna Smyrna Tennessee 37167 —
West Nashville West Nashville Tennessee 37209 —
North Fort Worth Fort Worth Texas 76119 —
Tarrant County Fort Worth Texas 76119 —
Waco Waco Texas 76708 —
Waco West Waco Texas 76712 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01017627, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 2, 2010 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01017627 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →